DOPAMINE

Dopamine Adverse Events Reported to the FDA Over Time

How are Dopamine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Dopamine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Dopamine is flagged as the suspect drug causing the adverse event.

Most Common Dopamine Adverse Events Reported to the FDA

What are the most common Dopamine adverse events reported to the FDA?

Hypotension	37 (3.02%)
Blood Pressure Decreased	36 (2.93%)
Cardiac Arrest	36 (2.93%)
Medication Error	34 (2.77%)
Drug Ineffective	21 (1.71%)
Metabolic Acidosis	19 (1.55%)
Acute Respiratory Distress Syndrome	16 (1.3%)
Device Failure	16 (1.3%)
Ventricular Tachycardia	15 (1.22%)
Convulsion	14 (1.14%)
Device Malfunction	14 (1.14%)
	Show More
Drug Interaction	14 (1.14%)
Bradycardia	12 (.98%)
Incorrect Dose Administered	12 (.98%)
Renal Failure Acute	11 (.9%)
Multi-organ Failure	10 (.81%)
Death	9 (.73%)
Electrocardiogram St Segment Elevat...	9 (.73%)
Tachycardia	9 (.73%)
Arteriospasm Coronary	8 (.65%)
Condition Aggravated	8 (.65%)
Hypertension	8 (.65%)
Hypoxia	8 (.65%)
Propofol Infusion Syndrome	8 (.65%)
Wrong Drug Administered	8 (.65%)
Atrial Fibrillation	7 (.57%)
Cardio-respiratory Arrest	7 (.57%)
Circumstance Or Information Capable...	7 (.57%)
Drug Administration Error	7 (.57%)
Haemodynamic Instability	7 (.57%)
Loss Of Consciousness	7 (.57%)
Pneumonia	7 (.57%)
Pulse Absent	7 (.57%)
Pyrexia	7 (.57%)
Ventricular Fibrillation	7 (.57%)
Anuria	6 (.49%)
Blood Pressure Systolic Decreased	6 (.49%)
General Physical Health Deteriorati...	6 (.49%)
Myocardial Ischaemia	6 (.49%)
Renal Failure	6 (.49%)
Torsade De Pointes	6 (.49%)
Atrial Tachycardia	5 (.41%)
Blood Pressure Increased	5 (.41%)
Coma	5 (.41%)
Confusional State	5 (.41%)
Drug Dispensing Error	5 (.41%)
Drug Exposure During Pregnancy	5 (.41%)
Heart Rate Increased	5 (.41%)
Hyperkalaemia	5 (.41%)
Hypernatraemia	5 (.41%)
Hypoglycaemia	5 (.41%)
Oxygen Saturation Decreased	5 (.41%)
Oxygen Saturation Increased	5 (.41%)
Pericardial Effusion	5 (.41%)
Pneumothorax	5 (.41%)
Respiratory Failure	5 (.41%)
Sepsis	5 (.41%)
Supraventricular Tachycardia	5 (.41%)
Tachyarrhythmia	5 (.41%)
Vasoconstriction	5 (.41%)
Abdominal Distension	4 (.33%)
Alanine Aminotransferase Increased	4 (.33%)
Anaemia	4 (.33%)
Aspartate Aminotransferase Increase...	4 (.33%)
Cardiac Failure	4 (.33%)
Cardiogenic Shock	4 (.33%)
Depressed Level Of Consciousness	4 (.33%)
Device Leakage	4 (.33%)
Drug Toxicity	4 (.33%)
Extrasystoles	4 (.33%)
Extravasation	4 (.33%)
Haemoglobin Decreased	4 (.33%)
Nausea	4 (.33%)
Renal Impairment	4 (.33%)
Sinus Tachycardia	4 (.33%)
Thirst	4 (.33%)
Air Embolism	3 (.24%)
Anaphylactic Shock	3 (.24%)
Apnoea	3 (.24%)
Arrhythmia Supraventricular	3 (.24%)
Atrioventricular Block First Degree	3 (.24%)
Atrioventricular Block Second Degre...	3 (.24%)
Bacteraemia	3 (.24%)
Blood Chloride Decreased	3 (.24%)
Blood Pressure Abnormal	3 (.24%)
Blood Pressure Immeasurable	3 (.24%)
Brachial Plexus Injury	3 (.24%)
Choreoathetosis	3 (.24%)
Circulatory Collapse	3 (.24%)
Congenital Hypothyroidism	3 (.24%)
Depression	3 (.24%)
Device Occlusion	3 (.24%)
Diarrhoea	3 (.24%)
Drug Effect Decreased	3 (.24%)
Dyspnoea	3 (.24%)
Electrocardiogram Qt Prolonged	3 (.24%)
Encephalitis	3 (.24%)
Erythema	3 (.24%)
Flushing	3 (.24%)
Gangrene	3 (.24%)
Heart Sounds Abnormal	3 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Dopamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dopamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Dopamine

What are the most common Dopamine adverse events reported to the FDA?

Cardiac Arrhythmias	149 (12.14%)
Cardiac And Vascular Investigations	93 (7.58%)
Medication Errors	89 (7.25%)
Procedural And Device Related Injur...	52 (4.24%)
Decreased And Nonspecific Blood Pre...	48 (3.91%)
Therapeutic And Nontherapeutic Effe...	43 (3.5%)
Renal Disorders	34 (2.77%)
Respiratory	33 (2.69%)
Acid-base	32 (2.61%)
Infections - Pathogen Unspecified	30 (2.44%)
Neurological	27 (2.2%)
	Show More
Lower Respiratory Tract Disorders	24 (1.96%)
Coronary Artery	21 (1.71%)
Electrolyte And Fluid Balance Condi...	19 (1.55%)
Seizures	17 (1.39%)
Metabolic, Nutritional And Blood Ga...	16 (1.3%)
Fatal Outcomes	14 (1.14%)
Heart Failures	14 (1.14%)
Hepatic And Hepatobiliary	14 (1.14%)
Bacterial Infectious	13 (1.06%)
Gastrointestinal Signs	13 (1.06%)
Chemical Injury And Poisoning	12 (.98%)
Epidermal And Dermal Conditions	12 (.98%)
Hematology Investigations	12 (.98%)
Myocardial	12 (.98%)
Vascular	12 (.98%)
Arteriosclerosis, Stenosis, Vascula...	11 (.9%)
Hepatobiliary	11 (.9%)
Injuries	9 (.73%)
Movement Disorders	9 (.73%)
Renal And Urinary Tract Investigati...	9 (.73%)
Deliria	8 (.65%)
Vascular Hypertensive	8 (.65%)
Body Temperature Conditions	7 (.57%)
Enzyme	7 (.57%)
Muscle	7 (.57%)
Pleural	7 (.57%)
Administration Site Reactions	6 (.49%)
Allergic Conditions	6 (.49%)
Depressed Mood Disorders	6 (.49%)
Gastrointestinal Motility And Defec...	6 (.49%)
Glucose Metabolism Disorders	6 (.49%)
Water, Electrolyte And Mineral	6 (.49%)
Anemias Nonhemolytic And Marrow Dep...	5 (.41%)
Anxiety Disorders	5 (.41%)
Gastrointestinal Hemorrhages	5 (.41%)
Neonatal And Perinatal Conditions	5 (.41%)
Pericardial	5 (.41%)
Cardiac And Vascular Disorders Cong...	4 (.33%)
Cardiac Disorder Signs	4 (.33%)
Central Nervous System Vascular	4 (.33%)
Connective Tissue Disorders	4 (.33%)
Embolism And Thrombosis	4 (.33%)
Hematological And Lymphoid Tissue T...	4 (.33%)
Increased Intracranial Pressure And...	4 (.33%)
Obstetric And Gynecological Therape...	4 (.33%)
Ocular Neuromuscular	4 (.33%)
Product Quality Issues	4 (.33%)
Suicidal And Self-injurious Behavio...	4 (.33%)
Therapeutic Procedures And Supporti...	4 (.33%)
Abortions And Stillbirth	3 (.24%)
Bone, Calcium, Magnesium And Phosph...	3 (.24%)
Bronchial Disorders	3 (.24%)
Central Nervous System Infections A...	3 (.24%)
Coagulopathies And Bleeding Diathes...	3 (.24%)
Endocrine Disorders Congenital	3 (.24%)
Endocrine Investigations	3 (.24%)
Fetal Complications	3 (.24%)
Gastrointestinal Inflammatory Condi...	3 (.24%)
Gastrointestinal Vascular Condition...	3 (.24%)
Lifestyle Issues	3 (.24%)
Neonatal Respiratory	3 (.24%)
Physical Examination Topics	3 (.24%)
Respiratory And Pulmonary Investiga...	3 (.24%)
Urinary Tract Signs	3 (.24%)
Appetite And General Nutritional	2 (.16%)
Bone And Joint Therapeutic Procedur...	2 (.16%)
Cardiac Valve	2 (.16%)
Changes In Physical Activity	2 (.16%)
Fungal Infectious	2 (.16%)
Gastrointestinal	2 (.16%)
Gastrointestinal Stenosis And Obstr...	2 (.16%)
Gastrointestinal Therapeutic Proced...	2 (.16%)
Hearing	2 (.16%)
Impulse Control	2 (.16%)
Investigations, Imaging And Histopa...	2 (.16%)
Musculoskeletal And Connective Tiss...	2 (.16%)
Ocular Hemorrhages And Vascular	2 (.16%)
Peritoneal And Retroperitoneal Cond...	2 (.16%)
Tissue	2 (.16%)
Viral Infectious	2 (.16%)
Vision	2 (.16%)
White Blood Cell	2 (.16%)
Adrenal Gland	1 (.08%)
Angiedema And Urticaria	1 (.08%)
Bone And Joint Injuries	1 (.08%)
Cardiac Therapeutic Procedures	1 (.08%)
Communication Disorders	1 (.08%)
Cranial Nerve Disorders	1 (.08%)
Cutaneous Neoplasms Benign	1 (.08%)
Developmental	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Dopamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Dopamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.